No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
RGLS Regulus Therapeutics
- 1.5900
- +0.0400+2.58%
Close Dec 20 16:00 ET
- 1.5900
- 0.00000.00%
Post 20:01 ET
104.15MMarket Cap-1.56P/E (TTM)
1.6000High1.5101Low462.27KVolume1.5300Open1.5500Pre Close727.65KTurnover0.95%Turnover RatioLossP/E (Static)65.50MShares3.790052wk High1.20P/B77.37MFloat Cap1.080052wk Low--Dividend TTM48.66MShs Float3071.9974Historical High--Div YieldTTM5.80%Amplitude0.7600Historical Low1.5740Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
With 64% Institutional Ownership, Regulus Therapeutics Inc. (NASDAQ:RGLS) Is a Favorite Amongst the Big Guns
JonesTrading Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $8
Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences
Oppenheimer Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $7
Regulus Therapeutics Poised for Growth: Promising ADPKD Study Results and Strategic Milestones Drive Buy Rating
Buy Rating for Regulus Therapeutics Driven by Promising Clinical and Regulatory Prospects for RGLS8429
Heat List
US
Overall
Symbol
Price
% Chg
No Data